Skip navigation

Best Practices and Benchmarking to Ensure a Sustainable and Lean Finance Function

September 19-20, 2017
  • Boston, MA

CBI’s 4th Annual Financial Reporting for Newly Commercial Life Science Companies convenes Finance and Accounting professionals from growing, innovative life sciences organizations to discuss best practices to implement scalable financial reporting processes, mitigate risk and develop lean and efficient finance teams. Birthed from the success of CBI’s Life Sciences Accounting and Reporting Congress, this meeting hones in on the unique challenges faced by small and mid-sized biotechs and pharmaceutical companies as they transition from private to public, enter into collaborations and recognize revenue. Gain strategies to ensure regulatory compliance, train new team members, manage contracts and effectively communicate financial performance.

Highlights for 2017 Include:

  • Implement new FASB Revenue Recognition standard
  • Optimize finance involvement in collaboration contract negotiations
  • Discuss IPO and accrual software to discover the best finance systems for your company
  • Navigate the evolution of financial processes as your company matures
  • Develop people and talent within your finance organization
  • Network with an elite speaking faculty and industry thought leaders

Previous Attendee Acclaim:

Great speakers with industry and function knowledge that spoke directly to issues I deal with.

Controller, Selecta Biosciences

CBI continues to deliver very insightful accounting practices specifically related to the life sciences industry.

Director, Technical Accounting and Controls, Amgen

I received real-time answers and tools for questions I was getting from my company’s leadership.

Senior Manager, Finance and Accounting, Endo Health Solutions

Very informative and helpful.

Senior Manager, Cubist Pharmaceuticals

September 19-20, 2017 | Boston, MA

Financial Reporting for Newly Commercial Life Science Companies

Best Practices and Benchmarking to Ensure a Sustainable and Lean Finance Function

CBI’s 4th Annual Financial Reporting for Newly Commercial Life Science Companies convenes Finance and Accounting professionals from growing, innovative life sciences organizations to discuss best practices to implement scalable financial reporting processes, mitigate risk and develop lean and efficient finance teams. Birthed from the success of CBI’s Life Sciences Accounting and Reporting Congress, this meeting hones in on the unique challenges faced by small and mid-sized biotechs and pharmaceutical companies as they transition from private to public, enter into collaborations and recognize revenue. Gain strategies to ensure regulatory compliance, train new team members, manage contracts and effectively communicate financial performance.

Highlights for 2017 Include:

  • Implement new FASB Revenue Recognition standard
  • Optimize finance involvement in collaboration contract negotiations
  • Discuss IPO and accrual software to discover the best finance systems for your company
  • Navigate the evolution of financial processes as your company matures
  • Develop people and talent within your finance organization
  • Network with an elite speaking faculty and industry thought leaders

Previous Attendee Acclaim:

Great speakers with industry and function knowledge that spoke directly to issues I deal with.

Controller, Selecta Biosciences

CBI continues to deliver very insightful accounting practices specifically related to the life sciences industry.

Director, Technical Accounting and Controls, Amgen

I received real-time answers and tools for questions I was getting from my company’s leadership.

Senior Manager, Finance and Accounting, Endo Health Solutions

Very informative and helpful.

Senior Manager, Cubist Pharmaceuticals

September 19-20, 2017 | Boston, MA